MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Search

MEDNAX Inc

Lezárt

SzektorEgészségügy

21.34 -2.11

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

21.27

Maximum

21.77

Fő mutatók

By Trading Economics

Bevétel

32M

72M

Értékesítés

24M

493M

P/E

Szektor átlag

11.461

88.032

Profit margin

14.549

Munkavállalók

4,120

EBITDA

27M

96M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

-2.25% downside

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

374M

1.9B

Előző nyitás

23.45

Előző zárás

21.34

Hangulat hírek alapján

By Acuity

50%

50%

157 / 374 Rangsor szerint Healthcare

Technikai pontszám

By Trading Central

Bizalom

Very Strong Bullish Evidence

MEDNAX Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. dec. 31. 22:20 UTC

Fő piaci mozgatók

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

2025. dec. 31. 17:31 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

2025. dec. 31. 16:30 UTC

Fő piaci mozgatók

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

2025. dec. 31. 15:19 UTC

Fő piaci mozgatók

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

2025. dec. 31. 15:17 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

2025. dec. 31. 14:37 UTC

Fő piaci mozgatók

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

2025. dec. 31. 21:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. dec. 31. 21:13 UTC

Felvásárlások, összeolvadások, átvételek

10 People to Watch in Wealth Management in 2026 -- Barrons.com

2025. dec. 31. 20:40 UTC

Piaci beszéd

Dollar Posting Its Worst Year Since 2017 -- Market Talk

2025. dec. 31. 20:22 UTC

Piaci beszéd

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

2025. dec. 31. 19:50 UTC

Piaci beszéd

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

2025. dec. 31. 19:31 UTC

Piaci beszéd

Precious Metals Cap Off Record Runs -- Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

2025. dec. 31. 17:17 UTC

Piaci beszéd

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

2025. dec. 31. 17:16 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10M Stock-Buyback Program

2025. dec. 31. 17:15 UTC

Piaci beszéd

Global Commodities Roundup: Market Talk

2025. dec. 31. 17:00 UTC

Felvásárlások, összeolvadások, átvételek

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

2025. dec. 31. 15:57 UTC

Felvásárlások, összeolvadások, átvételek

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

2025. dec. 31. 15:54 UTC

Piaci beszéd

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

2025. dec. 31. 15:02 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1M of Shares

2025. dec. 31. 14:40 UTC

Felvásárlások, összeolvadások, átvételek

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

2025. dec. 31. 14:20 UTC

Piaci beszéd

Crude Futures On Track to End the Year With Losses -- Market Talk

2025. dec. 31. 13:46 UTC

Piaci beszéd

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

2025. dec. 31. 13:01 UTC

Eredményjelentés
Felvásárlások, összeolvadások, átvételek

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

2025. dec. 31. 11:10 UTC

Piaci beszéd

Copper Remains in Touching Distance of Record Highs -- Market Talk

2025. dec. 31. 10:46 UTC

Piaci beszéd

Euro on Track For Strong Annual Performance -- Market Talk

2025. dec. 31. 10:25 UTC

Piaci beszéd

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

2025. dec. 31. 10:23 UTC

Piaci beszéd

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

2025. dec. 31. 09:33 UTC

Piaci beszéd

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Társak összehasonlítása

Árváltozás

MEDNAX Inc Előrejelzés

Célár

By TipRanks

-2.25% elmozdulás lefelé

12 hónapos előrejelzés

Átlag 21.33 USD  -2.25%

Magas 24 USD

Alacsony 17 USD

4 Wall Street elemző 12 hónapos célárain alapulva a(z)MEDNAX Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

4 ratings

2

Vétel

2

Tartás

0

Eladás

Technikai pontszám

By Trading Central

12.945 / 14.48Támogatás & ellenállás

Rövid táv

Very Strong Bullish Evidence

Középtáv

Neutral Evidence

Hosszú táv

Bullish Evidence

Hangulat

By Acuity

157 / 374 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk MEDNAX Inc

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
help-icon Live chat